Walt Addison Linscott - 22 Dec 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Operating Officer
Signature
/s/ Walt Linscott
Issuer symbol
INDP
Transactions as of
22 Dec 2025
Net transactions value
+$110,475
Form type
4
Filing time
29 Dec 2025, 16:01:18 UTC
Previous filing
11 Apr 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Walt Addison Linscott filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 29 Dec 2025."

Quick Takeaways

  • This page summarizes Walt Addison Linscott's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 29 Dec 2025, 16:01.

What Changed

  • Previous filing in this sequence was filed on 11 Apr 2025.
  • Current net transaction value: +$110,475.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Linscott Walt Addison Chief Operating Officer C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK /s/ Walt Linscott 29 Dec 2025 0001648585

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INDP Common Stock Award $110,475 +54,421 +1088420% $2.03 54,426 22 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person acquired 54,421 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025.

Sponsored